Medical News

RSS

Pervasis Therapeutics reaches agreement with FDA on pivotal Phase 3 clinical trial for Vascugel

Pervasis Therapeutics, Inc. today announced that it has reached an agreement with the U.S. Food and Drug Administration (FDA) on the design of a pivotal Phase 3 clinical trial for Vascugel®, an investigational new drug for the prevention of hemodialysis access graft failure.

2 Feb 2010

American Diabetes Association announces 2010 schedule for free community health events

In an age of soaring health care costs and staggering diabetes prevalence, the American Diabetes Association announced today its 2010 schedule for free community health events throughout the country -- the American Diabetes Association EXPO.

2 Feb 2010

Serious liver disorder associated with use of HIV drug, FDA warns

The U.S. Food and Drug Administration today announced that non-cirrhotic portal hypertension, a rare, but serious, liver disorder, has been reported in some HIV patients taking Videx/Videx EC (didanosine).

2 Feb 2010

State Department authorization bill introduced

"Senate Foreign Relations Committee leaders John Kerry, D-MA, and Richard Lugar, R-IN, introduced a State Department policy bill for both fiscal 2010 and fiscal 2011" on Friday, Foreign Policy's blog, "The Cable," reports.

2 Feb 2010

Researchers identify antiviral small molecule that is effective against numerous viruses

Viruses are insidious creatures. They differ from each other in many ways, and they can mutate - at times seemingly at will, as with HIV - to resist a host of weapons fired at them. Complicating matters further is that new viruses are constantly emerging.

2 Feb 2010

MCADD screening is expensive but offers immense health benefits

Newborn screening for a metabolic disorder could lead to false positives -- adding stress to parents, costing money and possibly subjecting a baby to unnecessary follow-up treatment and dietary restrictions.

2 Feb 2010

VHGI sells Secure eHealth to WNDM

VirtualHealth Technologies, Inc. announced today that it has completed the sale of secure data and messaging provider, Secure eHealth, LLC, along with certain other technology assets to Wound Management Technologies, Inc. as previously announced in the January 11 press release. In addition to the sale of Secure eHealth, VHGI has also transferred all of the intellectual property assets of the real-time prescription drug monitoring business conducted by its subsidiary, VPS Holdings, LLC to Wound Management.

2 Feb 2010

Stem Cell Therapy International completes merger with Histostem of South Korea

Stem Cell Therapy International, Inc. announced that it has completed its merger with Histostem Ltd. of South Korea ("Histostem"), forming one of the first fully merged Pacific Rim stem cell companies and cord blood repositories with a U.S. entity.

2 Feb 2010

Health IT roundup: Buyers' remorse, usage survey

Huffington Post Investigative Fund: The federal government has made investing in electronic medical records a priority by channeling billions of dollars to help doctors and hospitals go paperless, "[b]ut there's also concern that the government may not be doing enough to ensure that taxpayer money isn't wasted on faulty systems. What's more, doctors often have little expertise in buying electronic health records, commonly called EHRs, and do not always know what questions to ask or what protections they should push for in their contracts, several industry consultants said in interviews."

2 Feb 2010

States continue push back against mandates in stalled health bills

Conservative lawmakers in 34 states "are forging ahead with constitutional amendments to ban government health insurance mandates" despite the idling health reform measures in Congress, The Associated Press reports.

2 Feb 2010

New research shows tumor suppressor p53 prevents cancer progression in cells

Cells missegregate a chromosome approximately once every hundred divisions. But don't be too alarmed: new research in the Journal of Cell Biology shows that the tumor suppressor p53 limits the growth of cells with incorrect numbers of chromosomes and prevents their progression toward cancer.

2 Feb 2010

Evidence suggests antidepressants may improve post-stroke recovery

Patients who received the antidepressant escitalopram following a stroke appeared to recover more of their thinking, learning and memory skills than those taking placebo or participating in problem-solving therapy, according to a report in the February issue of Archives of General Psychiatry, one of the JAMA/Archives journals.

2 Feb 2010

NHI closes $100M unsecured revolving credit facility to fund new healthcare real estate investments

National Health Investors, Inc. announced today it has closed on a $100 million unsecured revolving credit facility to fund new healthcare real estate investments. The new credit facility, which was provided by Regions Bank as agent and Pinnacle National Bank as a participating bank, bears interest at a margin of 250 basis points over LIBOR with a floor of 1% and matures in February 2011.

2 Feb 2010

Shire announces the Canadian availability of VYVANSE prodrug therapy for ADHD treatment

Canadian families managing Attention Deficit Hyperactivity Disorder (ADHD) have a new treatment option. Today, Shire plc, the global specialty biopharmaceutical company, announced the Canadian availability of VYVANSE (lisdexamfetamine dimesylate capsule), the first and only prodrug therapy approved for ADHD treatment in Canada.

2 Feb 2010

U.N. Secretary-General focuses on MDGs during African Union Summit

Addressing the 14th African Union (AU) Summit on Sunday, U.N. Secretary-General Ban Ki-moon called for African countries to maintain their commitment to the Millennium Development Goals (MDGs), "which include reducing poverty, disease and child mortality, ahead of their target date of 2015," BBC reports (1/31).

2 Feb 2010

DATATRAK International announces multi-center study on Renal Anemia

DATATRAK International, Inc., a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced the contract signing for a Phase IV, eight-year, 500-site, 5,000-patient study worth approximately $900,000 with a global specialty pharmaceutical and medication delivery company.

2 Feb 2010

Australian TGA approves IDSI's CT Laser Mammography system for inclusion on ARTG

Imaging Diagnostic Systems, Inc., a pioneer in laser optical breast imaging, announced today that the Australian Government Department of Health and Ageing Therapeutic Goods Administration has approved the CT Laser Mammography (CTLM®) system for inclusion on the Australian Register of Therapeutic Goods (ARTG).

2 Feb 2010

Cellectricon resumes litigation against Fluxion Biosciences over alleged patent infringement

Cellectricon AB today announced that it has resumed its litigation against Fluxion Biosciences, Inc. Cellectricon filed the lawsuit in July 2009 in the United States District Court for the Northern District of California alleging infringement of several United States patents issued or licensed to Cellectricon for microfluidic technology used in Cellectricon's state-of-the-art ion channel drug screening solution, the Dynaflow(R)HT System. Cellectricon's U.S. Patents Nos. 7,390,650, 7,470,518 and 7,563,614 have been asserted in the litigation, as well as U.S. Patent No. 5,376,252, which is owned by Gyros, and licensed to Cellectricon.

From Fluxion Biosciences 2 Feb 2010

More details on Obama's global health strategy expected along with budget release, Wall Street Journal reports

"The Obama administration is expected to propose in its fiscal 2011 budget Monday new funding to combat preventable and tropical diseases, malnutrition and other conditions afflicting the world's poor, as part of a strategy to broaden its approach to global health," the Wall Street Journal reports.

2 Feb 2010

Experimental vaccine reduced TB rate among HIV-positive people in Tanzania, Study finds

An experimental vaccine was found to reduce the rate of tuberculosis infections in patients living with HIV, "the first time a shot has been shown to reduce cases of the most common AIDS-related cause of death in poor nations," Bloomberg reports (Bennett, 1/29). Tuberculosis accounts for up to one-third of AIDS deaths worldwide, CBC News reports.

1 Feb 2010

Medical News

Pervasis Therapeutics reaches agreement with FDA on pivotal Phase 3 clinical trial for Vascugel

American Diabetes Association announces 2010 schedule for free community health events

Serious liver disorder associated with use of HIV drug, FDA warns

State Department authorization bill introduced

Researchers identify antiviral small molecule that is effective against numerous viruses

MCADD screening is expensive but offers immense health benefits

VHGI sells Secure eHealth to WNDM

Stem Cell Therapy International completes merger with Histostem of South Korea

Health IT roundup: Buyers' remorse, usage survey

States continue push back against mandates in stalled health bills

New research shows tumor suppressor p53 prevents cancer progression in cells

Evidence suggests antidepressants may improve post-stroke recovery

NHI closes $100M unsecured revolving credit facility to fund new healthcare real estate investments

Shire announces the Canadian availability of VYVANSE prodrug therapy for ADHD treatment

U.N. Secretary-General focuses on MDGs during African Union Summit

DATATRAK International announces multi-center study on Renal Anemia

Australian TGA approves IDSI's CT Laser Mammography system for inclusion on ARTG

Cellectricon resumes litigation against Fluxion Biosciences over alleged patent infringement

More details on Obama's global health strategy expected along with budget release, Wall Street Journal reports

Experimental vaccine reduced TB rate among HIV-positive people in Tanzania, Study finds

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Shaping the future of lab automation through AI and robotics

Latest News